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A  B  S  TR A  C  T  Several proteins from various animal tissues with possible transport 
function  have  been  briefly described,  with  emphasis  given  to  a  vitamin  D- 
induced  calcium-binding  protein (CaBP)  implicated  in  calcium  translocation 
across epithelial  membranes.  The  latter  protein was shown  to  be present  in 
the small intestine, colon, kidney,  and the uterus (shell gland)  of the chicken. 
CaBP was also found in the small intestine of the rat, dog, bovine, and monkey. 
This protein has been isolated in high purity from chick intestinal mucosa and 
some  of its  properties  determined.  Its  molecular  weight  is  about  28,000,  its 
formation constant, about 2.6  X  105 M -1, and its binding capacity,  1 calcium 
atom per protein molecule. Correlative studies have shown that CaBP concen- 
tration in intestinal mucosa varies with the calcium absorptive capacity of the 
gut,  thereby suggesting that CaBP is intimately involved in the process of cal- 
cium absorption.  CaBP has  been localized in  the brush border region  of the 
intestinal  absorptive cell and within  goblet cells.  Among other proteins men- 
tioned were  the  intrinsic  factor  required  for vitamin  B12 absorption  and  the 
protein(s)  associated with iron translocation. 
Plasma membranes,  to a  large degree, determine  the extent and rate of per- 
meation of substrates into  and  out of the cytoplasmic mass.  Contributing  to 
their  passive permeability  and  selectivity are various physical and  chemical 
properties of the membrane, such as its lipoid nature, the presence of aqueous 
channels,  and  the electrical  charges  associated with the cell surface and  the 
core of the channel.  These and other important aspects have been well docu- 
mented and have sometimes been amenable to detailed investigations by the 
use of artificially constructed membranes. Biological membranes,  in addition, 
have the capacity to transport certain substrates against thermodynamic gra- 
dients (active transport) and to support reactions which accelerate the transfer 
of certain  substrates  down their  electrochemical  gradients  (facilitated  diffu- 
sion).  Both of these latter  two processes are hypothetically carrier-mediated 
and, in recent years, carrier-like molecules have been implicated in an increas- 
ing  number  of  transport  systems.  These  systems  exhibit  certain  common 
characteristics  including  Michaelis-Menten  kinetics,  a  high  degree of struc- 
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tural  specifcity,  and relative stereospecificity. Because of the specificity de- 
manded,  it  is  usually  considered  that  the  carriers  are  proteins,  molecules 
having sufficient complexity to contain the required information to distinguish 
between chemically similar molecules. The de facto  existence of membrane- 
associated proteins having a  possible transport or carrier function is substan- 
tiated by the information given in the recent review article of Pardee (1) and 
the material presented at the present Symposium. 
There appears to be at least two classes of proteins implicated in transport, 
those that are readily released from the cell or cell surface by the osmotic shock 
technique of Heppel (2) or by cell homogenization, and those that are firmly 
bound  to  membranous cell  components and  which  can  be  solubilized  by 
reagents such as Triton X-100  (3) and NaI  (4). These may be designated as 
"soluble"  and "insoluble"  transport proteins, respectively, and the relation 
between these and solute movement, and between each other, is not clear at 
present. As an example of each, Anraku (5) has isolated a soluble protein from 
Escherichia  coli K-12 with a  high binding affinity for galactose; the insoluble 
"M"  (membrane)  protein of Kennedy and  Fox  (3),  also  from E.  coli,  ap- 
pears to interact with/~-galactosides during the transport reaction. 
A few binding proteins with possible transport function have been detected 
in animal tissues.  One of the first so designated is the membrane adenosine 
triphosphatase of the crab nerve and erythrocyte membrane; this enzyme is 
discussed in detail elsewhere in this volume. Others are the calcium-binding 
protein induced by vitamin D,  the intrinsic factor related to vitamin B12 ab- 
sorption by the intestine, the galactose-binding component of intestinal brush 
border, a possible iron-binding protein of intestinal mucosa, the blood protein, 
transferrin,  implicated in erythrocytic iron uptake, and a  shockable protein 
from kidney that binds transportable organic acids. These will be subsequently 
discussed although emphasis will be given to the first mentioned. 
CALCIUM-BINDING  PROTEINS 
The recognition of the existence of a  calcium-binding protein (CaBP)  in in- 
testinal mucosa was derived from studies on the mechanism of action of vita- 
min D.  It was early shown that the protein was not present in tissue derived 
from rachitic animals but began to appear in such animals after vitamin D 
had been administered. From the older, classical studies of Mellanby (6) and 
Nicolaysen (7), and as reviewed recently by Wasserman and Taylor (8), such 
treatment also restores the capacity of the intestine to absorb  calcium and 
eventually causes a  remission of the rachitic syndrome. Because of the close 
interconnections between calcium movement, vitamin D, and a possible trans- 
port protein, it was considered worthwhile to review briefly certain aspects of 
the effect of vitamin D  on calcium absorption and on cell behavior before 
describing the investigations on CaBP. ii6 s  TRANSPORT  PROTEINS 
Physiological Site of Vitamin D Action 
Schachter and Rosen  (9) showed several years ago that the intestinal epithe- 
lium of the rat contains a  mechanism for actively transporting calcium from 
lumen to plasma. The transport capacity was dependent upon the vitamin D 
status of the animal, as well as on other factors, such as age, calcium intake, 
gestation, etc. (10,  I 1). Based upon several types of studies with isolated muco- 
sal tissue, Schachter et al.  (12) proposed that the Ca pump is located on the 
serosal aspect of the epithelial cell and that, in addition, a facilitated diffusion 
process is available in the brush border region for mediating the entry of cal- 
cium into the cell. The first step in the absorptive process, i.e. cell entry, is not 
an  energy-dependent reaction whereas the second,  i.e.  active transport,  re- 
quires an intact energy supply. The serosal Ca pump also becomes functionally 
TABLE  I 
EFFECT  OF  VITAMIN  D  ON  THE  UNIDIRECTIONAL  FLUXES  OF  CALCIUM 
ACROSS  CHICK  DUODENUM  IN  VIVO* 
Vitamn Ds  Lumen --* plasma flux (JI,P)  Plasma --, lumva flux (Jl~,)  Flux ratio 
~moles/¢m hr 
--  0.72  4- 0.10  0.24  4- 0.08  0.30 
-t-  1.54  4- 0.12  0.52  4- 0.16  0.30 
*  Perfused  Ca  concentration  =  5.2  mu;  values  =  mean  -4-  SEM  of  five  to  six  animals  per 
group. 
Table reprinted by permission from the Amer. J. Physiol. 1962, 203: 221. 
inoperative when the concentration of Ca in the intestinal lumen is sufficiently 
high; absorption then occurs primarily by diffusion. 
The important questions from our viewpoint are: Where in the transport 
path does vitamin D  appear to act? Does it function at the first step, the second 
step, both steps, or elsewhere? Is it required for the functioning of the Ca pump 
or does it affect the pump only indirectly? Since, in Schachter's hands  (13), 
the vitamin D  response was less apparent in metabolically inhibited tissue, the 
view was expressed that the sterol was required for the operation of this uni- 
directionally oriented calcium transport system. Counter to this, Harrison and 
Harrison  (14,  15)  observed that,  under the conditions of their experiments, 
inhibiting conditions did not nullify the increased rate of transfer of calcium 
due to vitamin D, and proposed that the vitamin decreased the passive resist- 
ance of the absorptive cell to calcium movement. This could be by way of an 
alteration of membrane structure or by way of the stimulation of the synthesis 
of a  "diffusional facilitator." Some of our initial  studies were designed to ex- 
amine independently the physiological effect of the vitamin on calcium fluxes 
and in a  manner such that the results would  bear on the  above controversy WASSEI~AN, COI~ADINO, AND TAYLOR  Binding Proteins  and  Transport  Function  x l 7  s 
(16,  17).  It was reasoned that,  if the Ca pump were stimulated or activated, 
the unidirectional flux ratio of rachitic chicks should be less than that of vita- 
min D-treated chicks.  If the flux ratio remained the same, this would suggest 
that the permeability theory was probably correct. The data, part of which is 
presented in Table I, clearly showed that vitamin D  treatment increased both 
the efflux  (J,.p)  and  the influx  (Jp,.)  of Ca,  and  that the flux ratio  remained 
essentially unchanged.  The most obvious interpretation  was that the sterol in 
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FIGURE I.  Et~cct  of vitamin 133 on the duodenal absorption and mucosal tissue uptake 
of radiocaldum.  The dosing solution, contalnlng 47Ca and 4°Ca (I mg/ml), was placed 
in the lumen of a ligated segment of duodenum of anesthetized racldtic and vit~mln Ds-- 
treated chicks. At the time periods indicated, the duodenum was removed and then the 
residual radioactivity in the lumen and the mucosal content of the isotope were deter- 
mined by a previously described procedure (20). Each point represents the mean of five 
to six chicks. 
some manner enhanced the permeability of the epithelial barrier of the intes- 
tine,  allowing a  greater  movement  of Ca  in  both directions.  Of the two  hy- 
potheses previously offered, the one stating that the vitamin effect was by way 
of a  nonenergy-requiring  permeability  alteration  appeared  to  be the more 
likely one. 
In  respect to  the cellular  site of the response,  other  studies  were done  in 
which the uptake of either  intraluminal  47Ca or plasma 4~Ca by the mucosal 
tissue was determined. At the same time, the absorption of 47Ca or the "secre- 
tion"  of plasma  47Ca into  the lumen was also measured.  From  the data de- 
picted  in  Fig.  1,  it was  apparent  that  vitamin  D  treatment  enhanced  *TCa 
absorption  (per usual) and,  at the earlier time periods, enhanced the quantity zz8 s  TRANSPORT  PROTEIN  s 
of *7Ca associated with the mucosa. The rate of release of 47Ca by the mucosa 
was also stimulated by the treatment.  In regard to movement in the opposite 
direction,  the transfer  of plasma  4rCa to the intestinal  lumen was greater  in 
those chicks treated with the vitamin but, on the other hand,  the transfer from 
plasma to mucosal tissue was unaffected (Fig. 2). That is, in both studies there 
was an apparent increase in Ca transfer across the mucosal border of the ab- 
sorbing cell no matter whether Ca was derived from the lumen or the plasma 
and, from this, one may conclude that this region is at least one of the promi- 
nent sites of expression of the vitamin D  effect. These and other aspects of cal- 
cium transfer across the intestine were discussed recently (18). 
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Fzotnu~ 2.  Effect of vitamin D3 
on  the  transfer  of  47Ca from 
plasma to intestinal lumen and 
from plasma to mucosal tissue. 
The radiocalcium was injected 
intravenously into  rachitic  or 
vitamin Drtreated chicks. Prior 
to  this,  1  ml  of  0.15  t,i  NaC1 
was placed in a  ligated loop of 
duodenum. At  the  times  indi- 
cated,  the  duodenum  was  re- 
moved,  and  the  radioactivity 
content  of  the  duodenal  fluid 
and  the  mucosa  were  meas- 
ured,  as  described  previously 
(20).  The values represent  the 
mean  4-  SEM  of  five  to  six 
chicks. 
Molecular Basis of Vitamin D Action 
The administration of vitamin D  to a rachitic animal does not cause an imme- 
diate restoration of the absorptive process but requires several hours, the time 
depending  upon the dose level of the vitamin.  This lag effect was noted  by 
Lindquist  (19) in  1952 and a  typical time-response curve from our studies is 
shown in Fig. 3 (20). It is apparent that, at the dose level used (500 IU/chick), 
between 8-16 hr must transpire before a significant response occurs. Consider- 
able attention has been given to the events which take place within this period. 
These have been tentatively identified as:  (a)  the time required for the sterol 
to localize in the target tissue and at the appropriate intracellular site; (b) the 
time for possible transformation  of vitamin  D  to an  active metabolite;  and, 
finally,  (c) time required for the induction of the synthesis of a necessary com- 
ponent of the calcium transport system (2 I, 22). The transformation of vitamin 
D  to an active metabolite was first shown by Norman et al.  (23), using radio- 
actively labeled sterol.  A  metabolite was recently isolated  and  characterized WASSERMAN, CORRADINO, ANn TAYLOR  Binding Proteins and Transport Function  I 19  s 
by Blunt etal.  (24)  and found to be 25-hydroxycholecalciferol (Fig. 4).  The 
involvement of vitamin D  in protein synthesis was initially derived from the 
experiments of Eisenstein and Passavoy (25)  in which it was demonstrated that 
the hypercalcemia produced by massive doses of vitamin D  was prevented by 
pretreatment with  actinomycin D.  Actinomycin D  and  other  inhibitors  of 
protein synthesis, such as puromycin and cycloheximide, were later shown by 
several groups to inhibit the intestinal response of various species to vitamin D 
(26-28)  and, from this, the most reasonable hypothesis would be that the syn- 
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Delayed absorptive response to vitamin D3. At zero time, a group of rachitic 
chicks was given 500  IU vitamin D3 each. At the times indicated, the capacity of a 
ligated duodenal segment to absorb calcium was determined. The absorption period was 
30 min. Each value represents the mean 4- SEM of five to six chicks. Figure reprinted by 
permission from  the J.  Nutr.,  1962,  77:69. 
thesis of a  specific protein is induced by the vitamin.  In this same vein,  the 
incorporation of 3H-orotic acid and ~H-uridine into RNA of intestinal mucosa 
was shown to be stimulated by the prior injection of vitamin D; this response 
was also inhibited by actinomycin D  (29,  30). 
The subcellular localization of the vitamin is also consistent with the protein 
synthetic hypothesis since  both  Haussler  and  Norman  (31)  and  Stohs  and 
DeLuca  (32)  find this  sterol  in  highest concentration in  the  nucleus of the 
target tissue. There is disagreement as to whether it accumulates cn the nu- 
clear membrane or  is  bound  by specific structures within the  nucleoplasm. 
However, Haussler et al.  (33)  recently presented substantial evidence indicat- 
ing that labeled vitamin D3 associates with the chromatin of mucosal cells of I20  S  TRANSPORT  PROTEINS 
chick  intestine  and  that  there  is  competitive  inhibition  by  nonradioactive 
vitamin D2, D~, tachysterol-2, or tachysterol-3, but not by ergosterol or chol- 
esterol. Nearly all of the chromatin-bound vitamin was in  the form of the ac- 
tive metabolite. Actinomycin D  did not inhibit this reaction. 
The observation that vitamin D  administration to a rachitic animal causes 
a unique calcium-binding protein to be formed is direct evidence for the DNA- 
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FIGURE 4.  Structural  relationships  between  the  precursor  molecule,  the  parent  mole- 
cule, and an  active metabolite of vitamin  D3.  This active metabolite  of vitamin 1)~ was 
recently  characterized  by  Blunt  et  al.  (24)  and  shown  to  be  a  hydroxylated  form  of 
activated dehydrocholesterol  (vitamin ])3). 
RNA-protein  synthetic theory of vitamin D  action.  There  is,  on  the  other 
hand, data which does not appear to be consistent with this view. As an exam- 
ple, the release of Ca by isolated kidney mitochondria of the rat is accelerated 
when vitamin D  is added to the in vitro preparation. The time course of this 
response is sufficiently short to eliminate protein synthesis as an intermediate 
step and, in addition, this effect is insensitive to actinomycin D  (34).  Another 
actinomycin D-insensitive response to vitamin D  is the enhanced transfer of 
calcium across everted gut sacs of ileum from rats given extremely high levels 
of vitamin D  (40,000 IU) and incubated under anaerobic conditions (34).  In WASSERMAN, CORRADINO, ANn  TAYLOR  Binding  Proteins and Transport Function  ~2x  s 
order  to explain  these results,  one may hypothesize  that  vitamin  D  has two 
mechanisms of action, one via the protein synthetic pathway and the other by 
way of a  direct interaction  with cellular membranes,  the latter resulting  in a 
selective permeability change.  As an  alternative  hypothesis,  it was suggested 
that  the  primary  effect of the vitamin  is  to alter  membrane  permeability to 
calcium and,  as a  consequence of a  change in the intracellular  ionic environ- 
ment,  the  synthesis  of a  specific  protein  is  initiated.  These  aspects  require 
50 
4O 
z 
so 
kd 
Z  20 
g, 
tg~  ¢ 
g  Io  -c. 
z 
i 
10  -3 
R 
°~  c  __  -o 
TRIS  ~.  E3  .[], 
0  I  I  I 
10  -6  10  -5  10  .4 
Co  CONC (M) 
FIGURE 5.  Influence of vitamin Da on the 4sCa-binding activity of the supernatant fluid 
of homogenates  of chick  duodenal  mucosa.  The  assay  system  consisted  of Chelex  100 
resin (0.04 ml in 0.2 ml of buffer mixture),  1 ml of supernatant fluid,  and 0.1 ml radio- 
calcium solution. After mixing and centrifuging, an aliquot of the supernatant phase was 
counted.  The  symbols,  D  and  R,  refer  to  supernatant  fluids from vitamin D-treated 
and  untreated  rachitic  chicks,  respectively.  Each  point  represents  the  mean  of three 
values. Figure reprinted by permission from Science, 1966,  152:  791. 
further  study.  However,  the  bulk of the  evidence derived  from experiments 
with  physiological  levels  of vitamin  D  and  done  under  more  physiological 
conditions, strongly indicate that the primary event is the direct interaction of 
the vitamin or its metabolite with the genetic machinery of the target tissue. 
Isolation and Some Properties of tt~e Calcium-Binding Protein (CaBP) 
The first clue that vitamin  D  induces the formation of a  unique  protein  was 
derived from studies on the distribution of 45Ca between components of homo- 
genates  of intestinal  mucosa  from  rachitic  and  vitamin  D-treated  rachitic I22  S  TRANSPORT  PROTEINS 
chicks  (35).  Significantly more  of the  radiocalcium  remained  in  the  soluble 
phase of the mate-:ial from vitamin D-treated versus that from rachitic animals 
and most or all of this effect appeared to be due to the presence of a  factor in 
the vitamin D  tissue with a  capacity to bind Ca.  The proteinaceous nature of 
FIGURE  6.  Acrylamide  gel  electrophoretic  pat- 
tern of proteins in the supernatant fluids of mucosal 
homogenates.  The symbols, R  and D, refer to ma- 
terial from rachitic and vitamin D3-treated chicks, 
respectively. The arrow designates the band with 
which  the  vitamin  D-induced  calcium-binding 
protein  is  associated.  Figure reprinted by  permission 
from  Arch. Biochem. Biophys.,  1967,  119: 536. 
the factor was shown by the fact that it was nondialyzable, heat labile, trypsin 
and Pronase digestible, and excluded by a Sephadex G-25 column (36). 
The assay system for CaBP was based upon the ion exchange procedure of 
Briggs and Fleishman  (37)  and depended  upon the  competition  of the  resin 
and  the  soluble  binding  substance  for  added  radiocalcium.  With  this  assay 
procedure,  the  binding  activities  of the  vitamin  D  and  rachitic  supernatant 
fluids and  the buffer alone were determined and  the results,  as a  function of 
calcium concentration in the system, are shown in Fig. 5.  Clearly, the binding WASSERMAN, CORRADINO,  AND  TAYLOR  Binding  Proteins and Transport Function  I2 3  s 
activity of the vitamin D  supernatant was considerably greater than that of the 
rachitic supernatant or the buffer alone and that,  as the calcium concentration 
was increased,  the proportion of radiocalcium maintained  in the soluble phase 
of the vitamin D  supernatant decreased, suggesting that a binding component 
of the latter fluid was being saturated. A comparison of acrylamide gel electro- 
phoretic patterns also revealed that at least one protein was present in vitamin 
D  supernatant  which  could  not  be  visualized  in  the  rachitic  material  (cf. 
arrow, Fig. 6). This band was later shown to be, or have associated with it, the 
vitamin D-induced calcium-binding protein. 
The CaBP was obtained in high purity by the use of a  three-step fractiona- 
tion  procedure  which  included,  in  order:  (a)  ammonium  sulfate  treatment; 
(b)  gel filtration  on Sephadex G-100; and  (c) preparative disc acrylamide gel 
electrophoresis  (38). The product yielded a  single band on an analytical elec- 
trophoretic gel and a single Schlieren peak with the analytical ultracentrifuge. 
The molecular weight was estimated  to be in  the range of 25,000-28,000,  as 
determined by the use of a calibrated gel filtration column and by sedimenta- 
tion  equilibrium.  The  association  constant  between  Ca  and  the protein  was 
determined  by the procedure of Schubert et al.  (39)  and  found  to be about 
2.6  ×  10 a M -1. Those for Sr and Ba were observed to be about 3.0  ×  104 and 
5.8  ×  103  M -1,  respectively.  Analysis  of the  binding  data  indicated  that  1 
molecule of protein bound 1 atom of Ca. 
TISSUE  LOCALIZATION OF  CaBP  The vitamin D-induced calcium-binding 
protein  has  been  identified  in  all  segments  of the  small  intestine  (40),  the 
colon, 1 and  the kidney of the chick  (40),  and  the uterus  (shell  gland)  of the 
laying hen  (41).  Each  of these  are epithelial  tissues across which  calcium  is 
translocated.  CaBP has  not been found  in liver,  muscle,  pancreas,  or blood. 
Although  considerable effort was given  to uncovering  the presence  of CaBP 
in bone, the data have proven negative thus far. 
SPECIES  DISTRIBUTION  OF  CaBP  A  vitamin  D-induced  calcium-binding 
protein has been found in intestinal mucosa of the following species: chick (36), 
rat  (42),  dog  (43),  bovine,  and  monkey.  There  are  some differences in  the 
properties of these various proteins,  such as electrophoretic mobility and  sen- 
sitivity to proteolytic enzymes,  but detailed  studies in this direction  have not 
yet been carried out. 
CORRELATION  BETWEEN  CaBP  AND  CALCIUM  ABSORPTION  Knowing  that 
vitamin D  increases Ca absorption and observing that a product of vitamin D 
interaction with the target tissue is a calcium-binding protein,  is by itself sug- 
gestive evidence that  the product  (i.e.  CaBP)  is involved in the translocation 
process.  However,  other  evidence  is  required  to  build  a  substantial  case  in 
favor of this hypothesis. For example, it must be shown that the appearance of 
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CaBP  in the rachitic chick after vitamin  D  administration  precedes or at least 
accompanies  the  physiological change.  This  was  shown  to  be  approximately 
the situation in an earlier experiment  (36) and was investigated in more detail 
recently  (44).  Part of the latter study was to examine  the time required  for the 
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FIGURE  7.  Correlation  between  the  appearance  of CaBP  and  the  restoration of the 
calcium-absorptive mechanism by vitamin D3. At zero time, a  group of rachitic chicks 
were given either 100 1U or 5000  IU vitamin 133. At the periods designated above, the 
absorption of radiocalcium from a ligated segment of duodenum was measured; the ab- 
sorptive period was 1~ hr. CaBP in the duodenal mucosa of other similarly treated chicks 
at these same time periods was also measured. Three procedures were used: G, detection 
of the characteristic band on an acrylamide gel electrophoretic pattern;  I,  immunodif- 
fusion against a  CaBP-specific antibody; and R, Chelex  100 ion exchange assay. In the 
above figure, the periods at which CaBP was first  detected have been designated  by a 
G, I, or R. The symbol, A, refers to the time at which a significant increase in absorption 
was first  observed.  Each point represents the group mean of five to six chicks ±  SEM. 
Figure reprinted by permij~ion from Amer. Jr. Clin.  Nutr.,  1969,  22:  431. 
appearance  of CaBP  at  two  levels of vitamin  D,  one  at  a  physiological level 
(100 IU)  and one at a  pharmacologic  level (5000 IU).  By resorting to the most 
sensitive technique  available to us,  i.e. double  immunodiffusion,  it was shown 
that CaBP  is present in mucosal tissue at the same time that Ca absorption was 
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enhanced,  in spite of the fact that the 5000 IU dose decreased the lag time by 
about  10 hr  (Fig.  7). 
Another criterion would be that the concentration of CaBP in mucosal tissue 
should vary directly with the efficiency of the calcium-absorptive mechanism, 
particularly when vitamin D  is not limiting.  This was achieved by resorting to 
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FIGURE 8.  Effect of dietary  calcium level on  47Ca absorption  by  the  chick duodenum 
and  on  the  calcium-binding  activity  of  the  supernatant  fluid  of  duodenal  mucosa 
homogenates.  Chicks were raised on diets containing 0.08,  1.20,  or 2.32% Ca. Absorption 
of 47Ca by a ligated loop of duodenum was measured  (20) and, in  a  comparable  group  of 
chicks,  the calcium-binding activity of the supernatant  fluid of homogenates of the duo- 
denal mucosa was determined by the Chelex i00 ion exchange assay. 2 
the well-documented adaptation phenomenon,  the latter defined as the ability 
of the animal to alter its capacity to absorb Ca in response to the dietary intake 
of that element. Animals raised on a low calcium diet absorb more Ca per unit 
time per unit length of intestine  than  similar animals raised on a  normal cal- 
cium diet. As shown in Fig.  8,  this was adequately demonstrated  in the chick 
and,  as depicted  in  the  same figure,  the concentration  of CaBP increased  in 
parallel  fashion. 2 Again  a  relationship  between CaBP and  Ca absorption was 
2 Morrissey, R. L., and R. H. Wasserman.  1969. Unpublished data. In6  s  TRANSPORT  PROTEINS 
apparent.  These and other correlations strongly suggested  that the hypothesis 
is correct; i.e.,  CaBP functions in the translocation process. 
Further  it  was  demonstrated  that  CaBP  synthesis  is  inhibited  by  actino- 
mycin  D  (45),  and  that  the  concentration  of CaBP  in  intestinal  mucosa  is 
FIGURE 9.  Fluorescent antibody localization  of CaBP in histological section of duodenal 
tissue from vitamin D~-treated chick.  The sample was first  treated with CaBP-specific 
antiserum  from  rabbits,  then  with  fluoresceinisothiocyanate-conjugated  anti-rabbit 
serum from sheep.  Light areas represent specific fluorescence  due to presence of CaB[. 
Rachitic intestine  and  immunologically blocked  controls  exhibited  nonspecific  fluores- 
cence only.  ×  275. 
greater in younger than older animals and  greater in laying than  in  non-egg 
laying hens  (8). 
Two types of evidence,  that would  be unequivocal,  have not been achieved 
successfully.  One  would  be to place  CaBP  in  rachitic  mucosa and  restore  its 
absorptive capacity and,  secondly,  inhibit the response with a  specific reagent 
such as the antibody to CaBP. Neither of these have yet been accomplished. 
LOCALIZATION OF CALCIUM-BINDING  PROTEIN  An  antiserum shown to be WASSERMAN, CORRADINO, AND  TAYLOR  Binding Proteins and  Transport Function  I~ 7  s 
specific for CaBP by Taylor (46)  uas used in the indirect fluorescent antibody 
method of Weller and Coons (47)  for the purpose of localizing CaBP in intes- 
tinal  tissue.  Frozen  sections  of  duodenum  from  rachitic  and  vitamin  D3- 
treated rachitic chicks were used, and Fig. 9 shows the distribution of fluores- 
cence obtained. This pattern of fluorescence was shown to be immunologically 
FIGURE 10.  PAS-positive  regions of duodenal tissue illustrated in Fig. 9. The histological 
section was reacted with PAS-Weigerts (acid iron, hematoxylin) stain, then the same field 
was rephotographed.  The PAS-positive goblet cells and surface coat-microvillar  regions 
(black) correlate with the CaBP sites illustrated in Fig. 9.  ×  275. 
specific by the normal blocking reactions; i.e., substitution of either nonspecific 
or CaBP-adsorbed,  specific antiserum in place of specific antiserum. The pat- 
tern observed with rachitic intestine provided an additional control, in that it 
contained no CaBP and likewise exhibited no specific fluorescence. 
The correlation between the regions demonstrating specific fluorescence and 
the PAS (periodic acid-Schiff) positive areas is shown in Fig.  10. It can be seen 
that most PAS-positive goblet cells contain high concentrations of CaBP.  In 
addition,  specific  fluorescence was observed  to  cover  the  surface of the villi, i28  s  TRANSPORT  PROTEINS 
indicating that CaBP is  present  in  the surface coat-microvilli region of the 
cells lining the villar surfaces. The resolution obtainable with 6-/z frozen sec- 
tions does not allow a definitive localization of CaBP in either the mucopoly- 
saccharide  surface  coat  or  the  brush  border  (microvilli);  however,  when 
viewed at high magnification, a surface coat localization is the more probable. 
These results are analogous to those obtained by Nakane et al.  (48)  in which it 
was shown that a leucine-binding protein was localized in the cell envelope of 
E. coli.  In both cases, the binding proteins are located in "logical" positions to 
function as transport proteins. 
SPECULATION  ON  THE  MECHANISM  OF  ACTION  OF  CaBP  The exact function 
of CaBP in the translocation process  (if this is actually the case)  is, of course, 
unknown. Some speculation perhaps is warranted if only to serve as a starting 
point for subsequent experimentation. 
From physiological information, it  seems  that vitamin D-dependent cal- 
cium absorption is not necessarily dependent on an intact energy supply and, 
equating the vitamin D  mechanism with CaBP function, one may tentatively 
conclude that CaBP does not function as part of an active transport system. 
Pertaining to this same point, the Ca pump appears to be associated with the 
basal  membranes of the epithelial cell whereas CaBP is localized in highest 
concentration at the opposite pole of the cell, and most likely within the surface 
coat matrix. Further, the mucosal border has been identified as a region of the 
cell where vitamin D manifests an important part of its effect, and across which 
the translocation of calcium in both directions is enhanced. 
Assuming that these features are the most pertinent, at least three models 
can be offered, these being depicted in Fig.  11.  First,  CaBP may serve as a 
"diffusional facilitator," enhancing-the transfer of calcium across the micro- 
villar membrane and/or through the sea of anionic charges that exists within 
the surface coat (cf. Borle (49) for a description of the relationship between the 
extraneous surface coat of isolated HeLa cells and calcium binding). Because 
of the large binding affinity of CaBP, this molecule could successfully compete 
for luminal Ca with respect to the anionic groups in the surface coat. However, 
two difficulties arise  with this first suggestion. The protein must be  able  to 
penetrate through the core of the membrane in order to act as a  membrane 
facilitator and,  secondly, some mechanism must be  available to  release  Ca 
from the protein (unless a Ca sink of sufficient magnitude is maintained). 
A second possibility is that CaBP serves as an "intracellular carrier," facili- 
tating the movement of calcium through the cytoplasmic milieu. At the basal 
aspect of the cell, the transported Ca could be come attached to a component 
of the Ca pump and then be actively extruded from the cell or, in conjunction 
with a  dumping system, leave the cell by diffusion. This type of mechanism 
appears unlikely because it was estimated that insufficient CaBP is available to WASSERMAN, CORRAD1NO, AND  TAYLOR  Binding  Proteins and  Transport  Function  129  s 
complex all of the calcium in  transit when a  relatively high concentration of 
calcium  is  placed  in  the  intestinal  lumen;  thus,  CaBP  appears  to  function 
catalytically. 
The third possibility is that CaBP may act primarily as a  "microvillar con- 
centrator" of calcium, being analogous to an ion exchange resin and accumu- 
lating  Ca  in  the region  adjacent  to  the plasma  membrane.  The bound  Ca  is 
then available for the next step in the chain,  the transfer of the element across 
the membrane  into the cell cytoplasm. The latter step might involve another 
carrier of calcium. 
FIGURE  11.  Diagrammatic 
representation  of  speculative 
ways by which CaBP may func- 
tion.  The solid circle represents 
CaBP;  X  represents  an  intra- 
cellular,  soluble  complex  of 
calcium,  such  as  citrate;  the 
open circle with squiggle, the Ca 
pump. 
OTHER  POSSIBLE  TRANSPORT  PROTEINS 
There  are  several  other  animal  proteins  that  appear  to  be  involved  in  the 
transport  of specific substrates  into  the  cell.  One  of these,  "intrinsic  factor" 
(IF) has been studied for over 35 yr and its existence was suggested by Castle 
in  1930  (50).  He observed a  hematopoietic response in pernicious anemia pa- 
tients after normal human gastric juice, previously incubated with beef muscle, 
was introduced into the patient's stomach.  Castle was able to conclude on the 
basis  of this  and  other  experiments  that  normal  gastric juice  contained  an 
"intrinsic factor" lacking in  pernicious anemia  patients  that was essential for 
the absorption of some substance generated by the interaction between it and 
an "extrinsic factor" contained in certain foods, such as beef. It is now known ~3  o  s  TRANSPORT  PROTEINS 
that the "extrinsic factor" is vitamin  B12 which was first isolated in pure form 
in  1948 (51, 52)  and fully characterized  in  1955  (53).  Complete characteriza- 
tion  of IF has  not yet been realized,  but  it  appears  to  be a  glycoprotein  of 
molecular weight 50,000-60,000  (54) and formed in the stomach, perhaps,  in 
the chief cells  (55). 
The exact mechanism of IF-mediated B12 transport is unknown  but certain 
features have  been elucidated.  It  is known  that  IF,  though  produced  in  the 
stomach,  promotes  B12 absorption  in  the  small  intestine  (56).  It  is generally 
accepted that B~2 must combine with IF prior to absorption  (57,  58) and that 
calcium  is  necessary for  optimal  absorption  (58).  Very recent  evidence  has 
indicated  that there is a  specific receptor for the IF-B~2 complex in the intes- 
tinal surface coat.  In one study, fluorescein-labeled rabbit antibodies to ham- 
ster microvillous membranes  showed specific reaction with hamster  intestine 
brush borders (59). In a related study, IF-mediated attachment of B12 to brush 
borders isolated from hamster  small  intestine  was shown  to be prevented  by 
incubation in vitro with rabbit antiserum to hamster microvillous membranes 
(60).  Once  attached  to  the luminal  surface of the  intestinal  cell,  the  IF-B12 
complex may penetrate the cell as a unit but may be altered in transit since, in 
one study,  the vitamin  entering  intestinal  lymph,  though not dialyzable,  was 
devoid of IF activity  (61).  Serious doubt has  been cast on  this concept by a 
very recent  study,  however,  which  showed that  IF was not absorbed during 
the process of IF-mediated vitamin B,2 absorption  (62). 
There is a Bi2-binding factor in the blood, appearing both in normal humans 
and  in pernicious  anemia  patients  having  no gastrointestinal  IF.  This factor 
facilitates  uptake  of B~2 by reticulocyte-rich  erythrocyte  preparations  by an 
adsorption  mechanism  quite  similar  to  the  IF-mediated  B,2  uptake  by  the 
intestine  (63). The binding factor involved appears to be a ~-globulin and has 
been called  transcobalamin  II  (64).  It is possible to speculate  that  both  the 
"intrinsic factor" and transcobalamin  II-mediated B12 uptake are components 
of a  sequential  mechanism operating  to assure optimal  availability of B~2 for 
erythrocyte production  and/or  maturation. 
Specific proteins have also been implicated in the intestinal  absorption and 
erythrocytic uptake of iron.  In the former case,  apoferritin  was considered  to 
function  in  the transepithelial  movement of iron  (65).  Little support for this 
concept has developed and,  in fact,  the evidence on which  it was based  was 
highly circumstantial.  Ferritin was qualitatively estimated in guinea pig intes- 
tine by histological means and shown to increase with iron feeding (65). It was 
speculated  that  this  stored  iron  could  be called  upon  as needed  to maintain 
blood  levels  (66).  This  proposal  has  been  discounted  and  apoferritin  is  not 
even considered per se in a  recent model of intestinal  iron transport although 
the data presented are consistent with the presence of some carrier within the 
intestinal  cell  (67). WASSERMAN, CORRADINO, AND  TAYLOR  Binding  Proteins and Transport Function  I3I  s 
A  second iron-binding protein, gastroferrin, appears to be involved in in- 
testinal iron transport  (68)  but in a  negative sense. This protein is found in 
gastric juice and has the capacity to complex iron, perhaps rendering it un- 
available for absorption by the intestinal mucosa. Supporting this concept are 
two observations. In hemochromatosis, in which there is excessive iron absorp- 
tion, gastroferrin is absent (69). Iron-deficiency anemia caused by severe blood 
loss was associated with low gastroferrin levels which returned to normal after 
restoration of normal blood levels by transfusion (70). 
With regard to erythrocytic iron translocation, the case for the participation 
of a  specific protein, transferrin, is quite good. Transferrin is the major non- 
heme, iron-binding protein of serum. In studies of human red cell suspensions, 
the uptake of iron-laden transferrin was much greater than the uptake of apo- 
transferrin (71). Once attached to the red cell membrane, the iron is released 
into the red cell while the apotransferrin molecule becomes detached. The 
transferrin-mediated uptake of iron was  prevented by metabolic inhibitors 
with the iron accumulation process being far more sensitive to inhibition than 
the transferrin attachment step (71). 
Proteins have been suspected of being involved in other transport systems in 
animals but little is known of their nature. Transport of glucose by intestine 
(72, 73) and by the erythrocyte (4,  74, 75), for example, have been related to 
binding by proteins or protein-like substances. Similarly, work is proceeding 
on the purification of a carrier-like protein for organic bases  8 that was released 
by osmotic shock from the kidney (76). 
The investigations  from our laboratory were  supported  by National Institute of Health Grants 
AM-04652  and AM-06271-NTN,  and Contract AT(30-1)-2147  from the  United States  Atomic 
Energy Commission. 
REFERENCES 
1.  PARDE~, A. B.  1968. Membrane transport proteins. Science. 162:632. 
2.  HSP~EL, L. A. 1967. Selective release of enzymes from bacteria. Science. 156:1451. 
3.  Fox, C. F., and E. P. I~NNEDY. 1965. Specific labeling and partial purification of the M 
protein, a component of the 3-galactoslde transport system of Escherichia coli. Proc. Nat. 
Acad. &i. U.S.A. 54:891. 
4.  Bo~INSm, H.,  and W.  D.  STEm. 1966. Isolation of a  glucose-binding component from 
human erythrocyte membranes. Nature  (London). 211:1366. 
5.  A~Ku,  Y.  1968. Transport of sugars and amino acids in bacteria. I. Purification and 
specificity  of the galactose- and leucine-binding  proteins. J. Biol.  Chem. 243:3116. 
6.  MELLAr~Y, E.  1919. An experimental investigation on rickets.  Lancet. 196:409. 
7.  NlcoI.AYSmq R.  1937. The influence of vitamin D on the absorption of calcium and phos- 
phorus in the rat. Biochem. J. 31:122. 
8.  WAssE~an, R. H., and A. N. TAx,  OR.  1969. Some aspects  of the intestinal absorption of 
calcium, with special reference to vitamin D.  In Mineral Metabolism, An Advanced 
Treatise. C. L. Comar and F. Brormer, editors. Vol. III, p. 321. 
8 Magour, S., A. Farah, and A. Sroka. The partial purification of a carrier-like protein for organic 
bases from the kidney. Private communication. I32  S  TRANSPORT  PROTEINS 
9.  SCHACHTER,  ~)., and S. M. ROS,~N. 1959. Active transport of Ca  45 by the small intestine and 
its dependence on vitamin D. Amer. J. Physiol. 196:357. 
10.  SCHACHTER,  D., E. B. DOWDLE, and H. SCHEN~ER. 1960. Active transport of calcium by the 
small intestine of the rat. Amer. J. Physiol. 198:263. 
11.  KIMnERa, D. V., D. SCHACHTER, and H. SCHENm~R. 1961.  Active transport of calcium by 
intestine: effects of dietary calcium Amer. J. Physiol. 200:1256. 
12.  SCHACHTER, D., S. KOWARSr,  t, J. D. FIN:~ELSTEIN,  and R. W. MA. 1966. Tissue concentra- 
tion differences during active transport of calcium by intestine. Amer. J. Physiol. 211:1131. 
13.  ScaAcrrmR, D., D. V. KIMBERG, and H. SCrmNg.~R. 1961. Active transport of calcium by 
intestine: action and bio-assay of vitamin D. Amer. J. Physiol. 200:1263. 
14.  HARtUSON, H. E., and H. C. HAmUSON. 1960. Transfer of Ca  4~ across the intestinal wall in 
vitro in relation to action of vitamin D and cortisol. Amer. J. Physiol. 199:265. 
15.  HARI~ISON,  H.  E.,  and H.  C.  HARRISOn. 1965.  Vitamin D  and permeability of intestinal 
mucosa to calcium. Amer. J. Physiol. 208:370. 
16.  WASSEm~AN,  R.  H.,  and F. A. KALLWLZ.  1962. Vitamin D3 and unidirectional calcium 
fluxes across the rachitic chick duodenum. Amer. J. Physiol. 203:221. 
17.  WASS]~P.~AN,  R. H., A. N. TAYLOR, and F. A. KALLFELZ. 1966. Vitamin D and the transfer 
of plasma calcium to intestinal lumen in chicks and rats. Amer. J. Physiol. 211:419. 
18.  WASSEm~AN,  R.  H.  1968.  Calcium transport by the intestine: a  model and comment on 
vitamin D  action. Calc. Tiss.  Res. 2:301. 
19.  LmoQutsT,  B.  1952.  Effect of vitamin D  on  the  metabolism of radiocalcium in rachitic 
rats. Acta Paediat. 41  (Suppl.):86. 
20.  WASSSm~AN,  R.  H.  1962.  Studies on vitamin ]:)8 and the intestinal absorption of calcium 
and other ions in the rachitic chick. J. Nutr. 77:69. 
21.  DELucA,  H.  F.  1967.  Mechanism  of action and  metabolic fate  of vitamin  D.  Vitamins 
Hormones. 25:315. 
22.  NOlU~AN,  A. W. 1968. The mode of action of vitamin D. Biol. Rev. (Cambridge) 43".97. 
23.  NOm~AN,  A. W., J. LUND, and H. F. DELucA. 1964. Biologically  active forms of vitamin D8 
in kidney and intestine. Arch. Biochem. Biophys. 108:12. 
24.  BLUNT, J.  W., H.  F.  DELucA,  and  H.  K.  SCHNOES. 1968.  25-Hydroxycholecaleiferol: a 
biologically active metabolite of cholecalciferol. Chem. Commun. 14:801. 
25.  EISENSTEm, R.,  and  M.  PASSAVOY. 1964.  Actinomycin D  inhibits parathyroid hormone 
and vitamin D  activity. Proc. Soc. Exp. Biol. Med.  117:77. 
26.  ZULL,  J. E., E. CZAP,  NOWSKA-MJszTAL,  and H. F. DELucA. 1965. Actinomycin D inhibition 
of vitamin D  action. Science. 149:182. 
27.  NO,AN, A. W.  1965.  Actinomycin D  and the response to vitamin D. Science. 149:184. 
28.  BOSMANN, H. B., and P.  S. CHE~, JR.  1966. Actinomycin D  inhibition of vitamin D- and 
dihydrotachysterol-induced responses in the chick. J. Nutr. 90:405. 
29.  STOHS, S. J., J. E.  ZULL, and H. F. DELucA.  1967.  Vitamin D  stimulation of [3H]-orotic 
acid incorporation into ribonucleic acid of rat intestinal mucosa. Biochemistry 6:1304. 
30.  NORMAN,  A. W. 1966. Vitamin D mediated synthesis of rapidly labeled RNA from intestinal 
mucosa. Biochem. Biophys. Res. Commun. 23:335. 
31.  HAUSSLZR,  M. R., and A. W. NORMAN. 1967. The subcellular distribution of physiological 
doses of vitamin D~. Arch. Biochem. Biophys. 118:145. 
32.  STOHS, S. J., and H. F. DELucA.  1967. SubceUular location of vitamin D  and its metabo- 
lites in intestinal mucosa after a  10-IU dose. Biochemistry. 6:3338. 
33.  HAUSSLER, M. R., J. F. M~mTLE, and A. W. NORMAN. 1968.  The association of a metabo- 
lite of vitamin D~ with intestinal mucosa chromatin "in vivo". J. Biol.  Chem. 243:4055. 
34.  ZULL,  J. E., E. CZARNOWSKA-M~szTAL,  and H. F. DELucA.  1966.  On the relationship be- 
tween vitamin D  action and actinomycin-sensitive processes. Proc. Nat. Acad. Sci. U.S.A. 
55:177. 
35.  WASS~m~A~,  R. H., and A. N. TA~_~OR. 1963. Vitamin Dn inhibition of radiocalcium bind- 
ing by chick intestinal homogenates. Nature (London). 198:30. 
36.  WASS~R~A~, R. H., and A. N. TnYgo~.  1966. Vitamin  Ds-induced calcium-binding pro- 
rein in chick intestinal mucosa. Science. 152:791. WAss~.~a~,  CogR~mo,  ~-~  TA~-~OR  Binding  Proteins and Transport Function  I33  s 
37.  BgIaos, F. N., and M. FLmsx~a~. 1965.  Calcium binding by particle-free supernatants of 
homogenates of skeletal muscle. J. Gen. Physiol. 49:131. 
38.  WASSEm~AN,  R.  H., R. A. Co--too,  and A. N.  TAYLOR. 1968.  Vitamin D-dependent 
calcium-blnding protein. J. BioL  Chem. 243:3978. 
39.  SCmmZRT, J., E. R. RUSSELL, and L. S. M~gs, JR.  1950. DiSSociation constants of radium- 
organic acid complexes measured by ion exchange. J. Biol.  Chem. 185:387. 
40.  TA~rnOR, A. N., and R. H. WASS~.~AN. 1967.  Vitamin D3-induced calcium-binding pro- 
tein:  partial  purification,  electrophoretic visualization,  and  tissue  distribution.  Arch. 
Biochem. Biophys.  119:536. 
41.  CORg~a~INO, R. A., R. H. WASSE~.~, M. H. PtrBoLs, and S. I. CI-n~o.  1968. Vitamin Ds 
induction of a  calcium-binding protein in  the  uterus of the laying hen.  Arch.  Biochem. 
Biophys.  125:378. 
42.  KALLF~LZ, F. A., A. N. TAYLOR, and R. H. WASS~AN. 1967. Vitamin D-induced calcium 
binding factor in rat intestinal mucosa. Proc. Soc. Exp. Biol. Med.  125:54. 
43.  TAYLOR, A. N., R. H. WASSERMAa~,  andJ. JowsEY.  1968. A vitamin D-dependent calcium- 
binding protein in canine intestinal mucosa. Fed. Proc. 27:675. 
44.  EBEL,  J. G., A. N. TAYnOR, and R. H. WASSE~AN.  1969. The vitamin D-induced calcium- 
binding protein of intestinal mucosa: relation to vitamin D dose level and the lag period. 
Amer. J. Clin. Nutr. 22:431. 
45.  CORg~a~INO, R. A., and R. H. WASSERM.~. 1968. Actinomycin D inhibition of vitamin D3- 
induced  calcium-bindlng protein  (CaBP)  formation in  chick duodenal mucosa.  Arch. 
Biochem. Biophys.  126:957. 
46.  TAYLOR, A.  N.  1969.  Vitamin  Ds-induced  calcium-binding protein:  immunochemical 
and fluorescent antibody localization studies. Ph.D.  Thesis. Cornell University, Ithaca. 
47.  WELL,  R,  T.  H.,  and  A.  H.  CooNs.  1954.  Fluorescent antibody studies with  agents  of 
Varicella and Herpes Zoster propagated in vitro. Proc. Soc. Exp. Biol.  Med. 86:789. 
48.  N~a~ANE, P.  K.,  G.  E.  NICHOALDS, and  D.  L.  OXENDER. 1968.  Cellular localization of 
leucine-binding protein from Escherichia coli. Science. 161:182. 
49.  BoRnE, A. B.  1968.  Calcium metabolism in HeLa cells and the effects of parathyroid hor- 
mone. J. Cell Biol.  36:567. 
50.  CASTLe, W. B., W. C. TOWNSEND, and C. W. H~ATH. 1930.  Observations on the etiologic 
relationship of achylia gastrica to pernicious anemia.  III. The  nature of the reaction 
between normal gastric juice and beef muscle leading to clinical improvement and in- 
creased blood formation similar to the effect of liver feeding. Amer. J. Med. Sci.  180:305. 
51.  RICKES,  E. L., N. G. BRinK, F. R. KONIUSZKY,  T. R. WOOD,  and K. Fon~mRs. 1948. Crystal- 
line vitamin B12. Science. 107:396. 
52.  SMITH, E.  L.,  and L.  F. J.  PARKER. 1948.  Purification of anti-pernicious anemia factor. 
Biochem. J. 43:viii. 
53.  HODO~aN, D.  C., J.  I~CKWORTH,  J.  H. ROBERTSON, K. N. TRUEBLOOD, R. J. PgOSEN, and 
J.  G. WI-nTE, 1955.  The  crystal structure of the hexacarboxylic acid derived from BI~ 
and the molecular structure of the vitamin. Nature  (London).  176:325. 
54.  GR~SBZCK,  R. 1967. Intrinsic factor and the transcobalamins with reflections on the general 
function  and evolution of soluble transport proteins. Scand. J.  Clin.  Lab.  Invest. Suppl. 
95:7. 
55.  KEUNmG, F. J., A. Ams~s, E. M~NDEMA, and H. O. Nn~wlo.  1959.  Observations on the 
site of production of Castle's intrinsic factor in the rat. J. Lab.  Clin. Med. 53:127. 
56.  I~LL,  P. C., G. H. SPRAY, and K. B. TAYLOR. 1957. The site of absorption of vitamin 
Ba2 in the rat. Clin. Sci.  (London).  16:663. 
57.  Nn~wiG, H. O., S. C. Sn~N, and W. B. CASTLE. 1957. Mechanism of intrlnsic factor action 
in the gastrectomized rat. Proc. Soc. Exp.  Biol.  Med. 94:223. 
58.  I~RT,  V.  1959.  Mechanism of intrinsic factor action in everted sacs of rat small intes- 
tine. J. Clin. Invest. 38:102. 
59.  Kom,, W. L., J. S. T~R,  I. L. MACI~Nzr~, andR. M. DONALDSON,  JR.  1968. Antibodies 
to intestinal microvillous membranes. I. Characterization and morphologic localization. 
.7. Exp. Med.  128:357. x34 s  TRANSPORT  PROTEINS 
60.  MAcKENzIE,  I. L., R. M. DONALDSON,  JR., W. L. KOPP, andJ. S. TRIER. 1968. Antibodies 
to intestinal microvillous membranes.  II. Inhibition of intrinsic factor-mediated  attach- 
ment of vitamin B12 to hamster  brush borders. J. Exp. Med. 128:375. 
61.  BoAss,  A., and T. H. WILSON. 1964. Intestinal  absorption of intrinsic factor and BI~ intrinsic 
factor complex. Amer. J. Physiol. 207:27. 
62.  HinEs, J. D., A. ROS~NBERO, and J. w. HAmuS. 1968. Intrinsic  factor-mediated  radio-B12 
uptake in sequential incubation  studies using everted sacs of guinea pig small intestine: 
evidence that IF is not absorbed into the intestinal cell. Pro¢. So¢. Exp. Biol. Med. 129:653. 
63.  I~TmF, F. P., C. W. GOTTLmB, and V. I~P.B~.RT. 1966. Mechanism of vitamin Bx~ uptake 
by erythrocytes. J'. Clin. Invest. 45:1907. 
64.  HALL, C. A.,  and A. E. FmKL~m 1965. The  dynamics  of transcobalamln  II. A vitamin 
B12 binding substance in plasma.  J. Lab.  Clin. Med. 65:459. 
65.  GRAmfiK, S.  1946. Ferritin.  IX. Increase  of the protein apoferritin  in the gastrointestinal 
mucosa as a direct response to iron feeding. The function of ferritin in the regulation  of 
iron absorption.  J. Biol.  Chem. 164:737. 
66.  GRANICK,  S.  1954. Iron Metabolism.  Bull.  N.Y. Acad. Med. 30:81. 
67.  HELBOCK, H. J.,  and P.  SALTMAN. 1967. The transport of iron  by rat intestine.  Biochim. 
Biophys. Acta. 135:979. 
68.  DAws, P.  S., C. G. Lur~, and D. J. I~LI~R. 1967. Gastric  iron binding protein in iron 
chelation by gastric juice.  Nature (London). 214:1126. 
69.  DAms, P. S., C. G. LuI~, and D. J. DELLER. 1966. Reduction of gastric iron-binding  pro- 
tein in haemochromatosis.  Lancet.  II:1431. 
70.  Lug, C. G., P. S. DAms, and D. J. DELLER. 1967. Change in gastric iron-binding  protein 
(gastroferrin)  during iron-deficiency anaemia.  Lancet.  I:926. 
71. JANDL,  J. J., and J. H. KOTZ. 1964. The plasma-to-cell cycle of transferrin.  J. Clin. Invest. 
42:314. 
72.  FAUST, R. G., S-M. L. Wu, and M. L. FAGGARD. 1967. D-glucose: preferential  binding to 
brush borders disrupted  with Tris (hydroxymethyl)  ~minomethane.  Science. 155:1261. 
73.  F~.m~m, S. M.,  S. L. HART, and J. A. NIsslM. 1967. Glucose binding by homogenates  of 
intestinal mucosa. Nature (London). 213:985. 
74.  BONSALL,  R. W., and S. HUNT. 1966. Solubilization of a glucose-binding component of the 
red cell membrane.  Nature (London). 211:1368. 
75.  LEVmE,  M., and W. D. STEm. 1967. Techniques for analysis of glucose binding by human 
erythrocyte membranes.  Biochim. Biophys. Acta. 135:710. 
76.  Ross, C. R., N. I. PESSAH, and A. E. FARAH. 1969. Attempts to label the renal carrier  for 
organic bases with dibenamine.  J. Pharma¢ol. Exp.  Ther. In press. 
Discussion  from the Floor 
Felix  Bronner  (University  of Louisville,  Louisville,  Ky.): Dr.  Maddaiah  and  I, 
stimulated  by Dr.  Wasserman's  studies,  have  investigated  the  occurrence  of  this 
calcium-binding protein in rat mucosa and have studied  the amount of binding ac- 
tivity as a function of calcium intake.  We find, in agreement with what Dr. Wasser- 
man has shown,  that there is an inverse relationship between the amount absorbed 
and the amount bound; i.e., the amount of binding activity. 
When animals that have been on a high calcium diet are placed on a low calcium 
diet,  within  24  hr  the  amount of binding  activity increases  as  shown on the  slide 
(Fig.  1).  As can be  seen,  there was a  marked increase in calcium-binding activity, 
expressed as moles Ca X  10-u/rag protein, assayed by the Wasserman method. This 
increase was marked,  then decreased in intensity,  and stabilized  at about the  level WASSERMAN, CORRADINO, AND TAYIA3R  Binding  Proteins and Transport Function  I35  s 
you see on the right-hand  side of the slide. The animals on diet III were absorbing 
roughly 100 mg calcium per day, the animals on diet I  approximately 5 mg calcium 
per day. 
When you treat animals with an antibiotic such as puromycin you can inhibit the 
increase of binding activity shown on the left-hand side of the slide. We have not done 
the reverse. However, when you place animals that are on the low calcium diet and 
shift them to a  high calcium diet you see there is a decrease in activity. The increase 
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in activity, which can be inhibited  by puromycin, is not parathyroid dependent,  as 
animals that have been parathyroidectomized show behavior similar to that of intact 
animals. 
Studies are now in progress to further characterize the nature of this calcium-bind- 
ing substance which, in agreement with Dr. Wasserman, we believe is a  protein. We 
have preliminary evidence to this effect as 4~Ca activity coincides with the first pro- 
tein  peak when  the  material is passed  through  Sephadex  G-25  gel.  Moreover,  the 
activity disappears when the extract is digested with trypsin. The protein does not oc- 
cur in the brush borders of the mucosal cells (prepared by the method of D. Miller and 
R. K. Crane.  1961.  Anal. Biochem. 2:284).  Rather,  most of the activity is localized in 
the  microsomal  fraction  of  the  mucosal  cells  (as  determined  by  ultracentrifugal 
fractionation  studies). t36 s  TRANSPORT  PROTEINS 
Dr.  Wasserman:  It is not surprising  that CaBP was not observed to be associated 
with isolated brush borders since the protein is easily disengaged from the mucosal 
tissue by simple homogenization. The fluorescent antibody study, however, does tend 
to show that the protein is localized in the brush border region in vivo, but again the 
bonding between CaBP and the brush border material must be quite labile. 
Dr.  Geoffrey W.  G.  Sharp  (Massachusetts  General  Hospital):  In  connection with 
your suggestion that the calcium-binding protein is situated in the mucus layer and 
may be synthesized in the goblet cells, do you have evidence of specific nuclear locali- 
zation of vitamin D  in the goblet ceils,  or is it localized in most of the ceils? 
Dr.  Wasserman: We have no evidence on this point. 
Dr. Pardee:  Dr. Roseman asks whether it has carbohydrate in it. 
Dr. Wasserman:  We concluded from our previous analysis that CaBP would contain 
1%  or less  of a  glucose equivalent on a  weight basis.  This was done when limited 
amounts of purified protein were available. 
Mr.  Arthur  B.  Chausmer (State  University of New York,  Downstate):  The  other 
mediator of calcium absorption which springs to mind is parathyroid hormone. Have 
you looked for this  binding  protein under  the  influence of parathyroid  hormone? 
The second question I  have goes back to whether your aetinomycin itself will lower 
serum calcium in a parathyroidectomized rat. I  didn't notice whether you had given 
aetinomycin to an animal which was essentially normal, and whether you had noted 
any changes in serum calcium levels. 
Dr.  Wasserman:  No, we do not have any specific information on the influence of 
parathyroid hormone on the calcium-binding protein. The hormone, I'm sure, would 
not induce the synthesis of the protein. However, if vitamin D  is not limiting, it may 
possibly alter the concentration of CaBP in the target tissue. 
Regarding  the  actinomycin D  response,  several  groups  (Norman,  A.  W.  1965. 
Science.  149:134;  Zull, J.  E.,  et al.  1965.  Science. 149:182;  and Bosmann,  H. B., and 
P.  S.  Chen, Jr.  1966.  J. Nutr. 90:405) showed that the increment in  Ca absorption 
in rachitic animals due to vitamin D  treatment was prevented when they were given 
aetinomycin D  before  or  simultaneously with  the  vitamin.  If the  antibiotic  were 
administered several hours after the vitamin was  given,  little or no inhibition was 
noted, indicating that there was a  direct effect on the vitamin D-mediated process. 
However, H. E. Harrison and H. C. Harrison (Proc. Soc. Exp. Biol. Med. 1966.  121:312) 
observed  that  aetinomycin  D  decreased  Ca  absorption  by  raehitie  rats  and  this 
suggested that the antibiotic acted on the "transport system itself rather than on the 
enhancing effect of vitamin D  on this process." 
Dr. Joseph F. Gennaro (New York University): Is the anticalcium-binding  protein 
species-specific? 
Dr.  Wasserman:  The antibody formed against chick CaBP does not interact with 
the dog protein. 
Dr. Gennaro: Will the anti-mammalian  antibodies react with the chick CaBP? 
Dr.  Wasserman:  The chick CaBP antibody is the only antibody we have in hand. 
Dr. Gennaro: If you treated this tissue on the mueosal surface with neuraminidase, 
is it possible that you could eliminate this calcium-binding effect? Secondly, in your 
first electrophoresis slide you mentioned the increase in the staining intensity of the WAK'$ERMAN, CORRADINO, AND  TAYLOR Binding Proteins and  Transport Function  I37 s 
furthermost band, but the two above it also showed variations. Do you have any com- 
ments on that? 
Dr.  Wasserman:  In regard  to your first question,  those treatments have not been 
attempted as yet. 
You are quite correct in noting that there are other alterations in the gel electro- 
phoretic pattern of proteins due to vitamin D  treatment or to a  low calcium intake. 
In the  past,  however, we have  given attention  only to  CaBP and  its  characteristic 
band,  but eventually will attempt to characterize or at least gain some information 
on the other proteins. 
Dr.  George Nichols,  Jr.  (Harvard  Medical  School): Dr.  Wasserman,  I  have  two 
questions.  The first was somewhat similar  to  the  comments of the  last  gentleman, 
namely what are  the  effects of proteolytic enzymes on the  presence of the  protein? 
The second is: Have you yet had a  chance to see how the presence or absence of this 
protein on the surface may effect the actual transfer of calcium 45 across the mucosal 
membrane? Can you put the two together yet? 
Dr.  Wasserman:  You mean restore the system? 
Dr. Nichols:  Yes. 
Dr.  Wasserrnan:  We have  made  some attempts  in  this direction  but  thus far we 
have not been successful. 